The Legal Examiner Mark The Legal Examiner Mark The Legal Examiner Mark search twitter facebook feed linkedin instagram google-plus avvo phone envelope checkmark mail-reply spinner error close
Skip to main content

After two people died, Novartis AG has pulled its pain relief drug Prexige from the market in Australia. According to a story published in the Wall St. Journal, “Australia’s Therapeutic Goods Administration said it had received eight reports of serious liver reactions in patients taking the drug. “It seems that the longer people are on the medicine, the greater the chance of liver injury,” its principal medical adviser, Rohan Hammett, said in a statement.

The Swiss company said the drug — which isn’t sold in the U.S. — is still available in about 50 countries and is being rolled out in Europe. Australia is the only country where Prexige is available in a 200-milligram dose, as opposed to a 100-milligram dose elsewhere.”

For more information on this subject matter please refer to the section on Drugs, Medical Devices, and Implants.

Comments are closed.

Of Interest